Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activation in Henoch-Schönlein purpura

G C Smith1, J E Davidson, D A Hughes

  • 1Department of Nephrology, Royal Hospital for Sick Children, Glasgow, Scotland, UK.

Pediatric Nephrology (Berlin, Germany)
|August 1, 1997
PubMed
Summary

This study found no evidence of complement activation in children with Henoch-Schönlein purpura (HSP). Complement activation protein levels were similar in children with HSP and healthy controls, suggesting it does not play a key role in HSP pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trial.

Acta cardiologica·2023
Same author

Cystic Fibrosis screen positive, inconclusive diagnosis (CFSPID) to Cystic Fibrosis: Detecting disease with serial assessments.

Paediatric respiratory reviews·2023
Same author

PrEP Use, Sexual Behaviour, and PrEP Adherence Among Men who have Sex with Men Living in Wales Prior to and During the COVID-19 Pandemic.

AIDS and behavior·2022
Same author

Using routinely recorded data in a UK RCT: a comparison to standard prospective data collection methods.

Trials·2021
Same author

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.

Molecular genetics and metabolism·2021
Same author

Assessing development and climate variability impacts on water resources in the Zambezi River basin. Simulating future scenarios of climate and development.

Journal of hydrology. Regional studies·2020

Area of Science:

  • Immunology
  • Pediatrics
  • Rheumatology

Background:

  • The exact cause of Henoch-Schönlein purpura (HSP) remains unclear.
  • While complement system activation is suspected, serological evidence has been inconclusive.
  • Previous studies noted complement components in biopsies but lacked convincing blood test results.

Purpose of the Study:

  • To investigate the role of complement activation in the development of acute Henoch-Schönlein purpura (HSP).
  • To measure specific complement activation protein (CAP) complexes in children with HSP.

Main Methods:

  • Enzyme-linked immunosorbent assays (ELISAs) were used to quantify plasma levels of three CAP complexes.
  • The CAP complexes measured were C1r:C1s:C1-inhibitor, C3bP, and C5b-9.
  • Levels were compared between 64 children with acute HSP and a control group.

Related Experiment Videos

Main Results:

  • No significant differences were observed in the plasma levels of the measured CAP complexes between children with acute HSP and the control group.
  • The findings indicate that complement activation, as measured by these specific protein complexes, is not elevated in acute HSP.

Conclusions:

  • This study does not support a significant role for complement activation in the pathogenesis of Henoch-Schönlein purpura (HSP).
  • Further research may be needed to explore other potential pathways involved in HSP development.